The trading price of Mind Medicine Inc (NASDAQ:MNMD) floating higher at last check on Tuesday, April 23, closing at $9.09, 4.72% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $12.22 and a 52-week low of $2.41. Over the past month, the stock has lost -7.06% in value.
Mind Medicine Inc, whose market valuation is $255.97 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.53 per share this quarter, however they have predicted annual earnings per share of -$1.58 for 2024 and -$1.5 for 2025. It means analysts are expecting annual earnings per share growth of 35.20% this year and 5.10% next year.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Mind Medicine Inc no upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest MNMD has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
A quick review shows that MNMD’s price is currently -8.79% off the SMA20 and 13.02% off the SMA50. The RSI metric on the 14-day chart is currently showing 48.49, and weekly volatility stands at 7.35%. When measured over the past 30 days, the indicator reaches 10.07%. Mind Medicine Inc (NASDAQ:MNMD)’s beta value is currently sitting at -6.74, while the Average True Range indicator is currently displaying 0.89.
To see how Mind Medicine Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: MNMD stock’s performance was 4.72% at last check in today’s session, and 130.13% in the past year.
An evaluation of the daily trading volume of Mind Medicine Inc (NASDAQ:MNMD) indicates that the 3-month average is 2.23 million.
Currently, records show that 41.10 million of the company’s shares remain outstanding. The insiders hold 4.34% of outstanding shares, whereas institutions hold 61.39%. However, since the stock’s price has seen 148.36% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
